Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis

被引:0
|
作者
Zhou Zhou
Shi Liu
Meng Zhang
Rui Zhou
Jing Liu
Ying Chang
Qiu Zhao
机构
[1] Zhongnan Hospital of Wuhan University,Department of Gastroenterology, Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases
来源
Digestive Diseases and Sciences | 2017年 / 62卷
关键词
Pancreatic ductal adenocarcinoma; Co-Expression analysis; Prognosis; Tumor progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2790 / 2800
页数:10
相关论文
共 50 条
  • [21] Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer
    Zhou, Qiang
    Ren, Jiangbo
    Hou, Jinxuan
    Wang, Gang
    Ju, Lingao
    Xiao, Yu
    Gong, Yan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (09) : 2383 - 2396
  • [22] Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer
    Qiang Zhou
    Jiangbo Ren
    Jinxuan Hou
    Gang Wang
    Lingao Ju
    Yu Xiao
    Yan Gong
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2383 - 2396
  • [23] Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma
    Deichmann, Steffen
    Schindel, Leif
    Braun, Ruediger
    Bolm, Louisa
    Taylor, Martin
    Deshpande, Vikram
    Schilling, Oliver
    Bronsert, Peter
    Keck, Tobias
    Ferrone, Cristina
    Wellner, Ulrich
    Honselmann, Kim
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (08) : 541 - 547
  • [24] Membranous co-expression of EpCAM and CD44s predicts poor prognosis in pancreatic cancer patients
    Xu, Bao-Qing
    Meng, Yao
    Fan, Xin-Yu
    Ma, Lan-Xiang
    Qin, Jun
    Chen, Zhi-Nan
    Li, Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 832 - +
  • [25] Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma
    Kudo, Yuzan
    Sato, Norihiro
    Adachi, Yasuhiro
    Amaike, Takao
    Koga, Atsuhiro
    Kohi, Shiro
    Noguchi, Hirotsugu
    Nakayama, Toshiyuki
    Hirata, Keiji
    PANCREATOLOGY, 2020, 20 (07) : 1479 - 1485
  • [26] Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma
    Chen, Jun
    Zhang, Hao
    Luo, Jiansheng
    Wu, Xiaokang
    Li, Xueming
    Zhao, Xinyi
    Zhou, Dongkai
    Yu, Shian
    ONCOLOGY LETTERS, 2018, 16 (01) : 199 - 210
  • [27] Kindlin-2 Expression in Peritumoral Stroma Is Associated With Poor Prognosis in Pancreatic Ductal Adenocarcinoma
    Mahawithitwong, Prawej
    Ohuchida, Kenoki
    Ikenaga, Naoki
    Fujita, Hayato
    Zhao, Ming
    Kozono, Shingo
    Shindo, Koji
    Ohtsuka, Takao
    Mizumoto, Kazuhiro
    Tanaka, Masao
    PANCREAS, 2013, 42 (04) : 663 - 669
  • [28] Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Yin, Jingyang
    Guo, Shixiang
    Yang, Jiali
    Xia, Renpei
    Wang, Huaizhi
    PANCREAS, 2025, 54 (01) : e11 - e17
  • [29] GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co-expression network analysis
    Yuan, Jingsheng
    Tan, Lulu
    Yin, Zhijie
    Tao, Kaixiong
    Wang, Guobing
    Shi, Wenjia
    Gao, Jinbo
    ONCOLOGY REPORTS, 2019, 41 (01) : 191 - 201
  • [30] Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer
    Chen, Peng-Fei
    Wang, Fan
    Nie, Jia-Yan
    Feng, Jue-Rong
    Liu, Jing
    Zhou, Rui
    Wang, Hong-Ling
    Zhao, Qiu
    ONCOTARGETS AND THERAPY, 2018, 11 : 6425 - 6436